Full history for every metric is available with a Kvantra account
Ascendis Health Limited (ASC.JO)
Key financial summary
Financials in ZAR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | ZAR m | 6,963 | 1,825 | 1,559 | 1,535 | 1,472 | 0 | 0 |
| Operating profit | ZAR m | -26 | -26 | |||||
| Net profit | ZAR m | -966 | -1,091 | 449 | 75 | 57 | 11 | 11 |
| EPS reported | ZAR | 0.02 | 0.02 | |||||
| Operating cashflow per share | ZAR | -0.02 | -0.02 | |||||
| Capex per share | ZAR | 0.00 | 0.00 | |||||
| FCF per share | ZAR | -0.02 | -0.02 | |||||
| Free cash flow | ZAR m | -12 | -12 | |||||
| Net debt | ZAR m | 103 | 103 | |||||
| Book value equity | ZAR m | 630 | 630 | |||||
| Book value per share | ZAR | 1.01 | 1.01 | |||||
| Number of shares | m | 626.05 | 626.05 | |||||
| DPS (TTM paid) | ZAR | 0.00 | 0.00 |
Financial summary
Financials in ZAR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 47.78 | - | |||||
| P/B LTM | x | 0.85 | 0.91 | |||||
| P/S LTM | x | 0.00 | 0.00 | |||||
| P/FCF LTM | x | -43.49 | -46.52 | |||||
| EV/EBITDA LTM | x | -16.57 | 59.78 | |||||
| EV/Sales LTM | x | 0.00 | 0.00 | |||||
| Earnings Yield LTM | % | 2.09% | 1.96% | |||||
| FCF Yield | % | -2.30% | -2.15% | |||||
| Quality | ||||||||
| ROE | % | 1.79% | 1.81% | |||||
| ROIC | % | -2.35% | -2.35% | |||||
| Operating margin | % | 0.00% | 0.00% | |||||
| Gross margin | % | 0.00% | 0.00% | |||||
| FCF/Sales | % | - | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -72.89% | -72.89% | |||||
| Sales Growth YoY | % | -100.00% | -100.00% | |||||
| Net Income Growth YoY | % | -80.32% | -80.32% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.12 | -0.12 | |||||
| Net Debt/EBITDA | x | -2.68 | -2.68 | |||||
| EBIT/Net interest | x | -3.06 | -3.06 | |||||
| Net debt/market cap | % | 19.05% | 17.81% | |||||
| Net debt/Equity | x | 0.16 | 0.16 | |||||
| Gross debt/equity | x | 0.17 | 0.17 | |||||
Company overview
Ascendis Health Limited is a health and wellness enterprise that manufactures and distributes healthcare products across South Africa, Cyprus, Spain, Hungary, Romania, and other international markets. The company's operations are divided into three key segments: Consumer Health, Pharma, and Medical. Within its Consumer Health portfolio, it offers a variety of body and skin care items, alongside numerous supplements such as natural, multi-vitamin, mineral, micronutrient, and nutraceutical options, as well as homeopathic and herbal remedies, marketed under brands like Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce. The Medical segment provides essential medical devices, diagnostic laboratory equipment, and related consumables for diverse settings, including operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, and scientific research institutes. Concurrently, the Pharma division offers a wide array of generic pharmaceutical products, encompassing antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives, and treatments targeting the nervous and cardiovascular systems, dermatological issues, and antimalarial conditions, among other therapeutic solutions. These medical and pharmaceutical products are distributed under brands such as Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group. Ascendis Health also exports its products and serves a broad customer base including pharmacies, retailers, beauticians, and doctors. The company was founded in 2008 and is headquartered in Johannesburg, South Africa.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Ascendis Health Limited (ASC.JO)
Ascendis Health Limited is a health and wellness enterprise that manufactures and distributes healthcare products across South Africa, Cyprus, Spain, Hungary, Romania, and other international markets. The company's operations are divided into three key segments: Consumer Health, Pharma, and Medical. Within its Consumer Health portfolio, it offers a variety of body and skin care items, alongside numerous supplements such as natural, multi-vitamin, mineral, micronutrient, and nutraceutical options, as well as homeopathic and herbal remedies, marketed under brands like Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce. The Medical segment provides essential medical devices, diagnostic laboratory equipment, and related consumables for diverse settings, including operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, and scientific research institutes. Concurrently, the Pharma division offers a wide array of generic pharmaceutical products, encompassing antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives, and treatments targeting the nervous and cardiovascular systems, dermatological issues, and antimalarial conditions, among other therapeutic solutions. These medical and pharmaceutical products are distributed under brands such as Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group. Ascendis Health also exports its products and serves a broad customer base including pharmacies, retailers, beauticians, and doctors. The company was founded in 2008 and is headquartered in Johannesburg, South Africa.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free